Reviva Pharmaceuticals
RVPH
RVPH
46 hedge funds and large institutions have $3.12M invested in Reviva Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.03% less ownership
Funds ownership: 13.71% → 9.69% (-4%)
11% less capital invested
Capital invested by funds: $3.52M → $3.12M (-$394K)
Holders
46
Holding in Top 10
–
Calls
$1.83M
Puts
$246K
Top Buyers
| 1 | +$709K | |
| 2 | +$371K | |
| 3 | +$308K | |
| 4 |
Millennium Management
New York
|
+$307K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$272K |
Top Sellers
| 1 | -$1.39M | |
| 2 | -$330K | |
| 3 | -$79.8K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$63K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$20.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| – |
|
|||
52
SG Americas Securities
New York
| – |
|
|||
|
DWM
53
Drive Wealth Management
Lehi,
Utah
| – |
|
|||
|
IAS
54
Insigneo Advisory Services
Miami,
Florida
| – |
|